Acromegaly Update podcast

Acromegaly Update — Monday August 31, 2026

0:00
7:00
Rewind 15 seconds
Fast Forward 15 seconds
It's a quiet week for acromegaly-specific research — no top-tier trials, just a handful of diagnostic and mechanistic papers — while rare disease industry news brought two new FDA approvals (Priovant's Lisraya for dermatomyositis and Takeda/Protagonist's Mimrylo for polycythemia vera) that show regulators keep clearing novel mechanisms for small patient populations.

More episodes from "Acromegaly Update"